Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979.
about
Evaluation and optimization of a commercial enzyme linked immunosorbent assay for detection of Chlamydophila pneumoniae IgA antibodiesChlamydia pneumoniae and atherosclerosis.A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis.Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections.Prevalence of specific antibodies to Chlamydia pneumoniae in KoreaProtective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leukopenic mice.Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland.Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae.Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of humans and koalas.Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals.Inflammation, infection and antimicrobial therapy in coronary heart disease--where do we currently stand?Immunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathologyComparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections.Chlamydia pneumoniae (TWAR).Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profileChlamydia pneumoniae and asthmaA population based seroepidemiological survey of Chlamydia pneumoniae infections in schoolchildren.Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untestedLaboratory diagnosis of Chlamydia pneumoniae infections.Chlamydia pneumoniae pneumonia: An evolving clinical spectrum.Chlamydia pneumoniaeHigh prevalence of antibodies to Chlamydia pneumoniae; determinants of IgG and IgA seropositivity among Jerusalem residentsReview: variability of host-pathogen interaction.Stability of Chlamydophila pneumoniae in a harsh environment without a requirement for acanthamoebae.Type III secretion, contact-dependent model for the intracellular development of chlamydia.Infections and vaccinations preceding childhood Guillain-Barré syndrome: a prospective study.Serum IgG and IgA antibodies to Chlamydia pneumoniae and severity of emphysema.Why Chlamydia pneumoniae is associated with asthma and other chronic conditions? Suggestions from a survey in unselected 9 yr old schoolchildren.A prospective study of Chlamydia pneumoniae antibodies in children between 7 months and 8 years of age.Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial.The microimmunofluorescence test for Chlamydia pneumoniae infection: technique and interpretation.Chlamydial antibodies in an elderly Finnish population.Chlamydia pneumoniae infection and ethnic origin.Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm.Chlamydia pneumoniae and its role in chronic obstructive pulmonary disease.Infection of Acanthamoeba castellanii by Chlamydia pneumoniae.Demonstration of Chlamydia pneumoniae in patients with chronic pharyngitis.Transport and storage conditions for cultural recovery of Chlamydia pneumoniae.Characterization of a Chlamydia pneumoniae strain isolated from a 57-year-old man.
P2860
Q33355197-7D112477-9629-4A1E-8D13-4B77AC3570EDQ33534714-2C91F1FA-FD21-4EC6-902A-1C290773CAE3Q33596734-154DF2F9-6E74-4A04-A055-5EE2DC3600A2Q33676311-DEA803F6-037D-4D6E-ADE6-7E7EE3484922Q33688588-6DB42E95-5AB8-463D-9D79-E579C0D407F7Q33756547-1A3F32D0-B37B-4BED-B8C8-710B09E3C9ABQ33788646-459CA7DD-368D-4878-9AE6-590191A67489Q33935003-7459AE14-8803-47D1-BA7B-E333313A7094Q33998580-544B3168-AA97-4902-BBD4-E5A06A9AE882Q34004325-AABD100C-159E-4140-82B0-40CB63A309E2Q34203352-A03BA62C-C39C-4FEC-A22D-B7A245B33CF4Q34316462-2DFB12F8-F031-450D-AA3C-A0F387F36CDBQ34685461-A18026FB-0B74-4BE6-BFBF-974F641837CEQ34781808-F5BA85FF-7DE4-430B-BCCF-9274BF84F4CBQ35367697-020A6F45-46DD-49F7-9D0A-6D3437AC06B3Q35370873-B6060AC7-74BC-4652-B80A-33EE2E08A2D9Q35532326-B59500FC-59F9-423E-A10F-1297E5B588B8Q35588641-6AAE7C03-16F6-49BC-A30C-DC8269E4FF1DQ35821202-4592A6DE-118F-440D-866C-83E0DC85DC6BQ35892967-99A781C7-839C-4079-AD9E-557E44F6F626Q35892972-60105ED0-0285-4571-88F0-403CAEA3BD82Q36272565-86C19887-B11A-428B-9B5A-53EF191E06AEQ36503604-97F75568-9579-4FB5-B44F-F77279038879Q36980187-6596AC2A-FD25-45D0-8314-96849E2B904CQ37853293-ADCFA5C4-7707-44AD-A7B8-26D2592F2943Q37861994-75686AF9-2EEF-476E-8FD3-D12E05F5D2FCQ37862292-9A71264A-23DF-4261-80C5-175F43766A3AQ37863634-503AD7C8-CB7A-4B72-A9FB-7B574E4B9027Q37865213-A178A087-D6F5-414C-BE29-A1A33FDCF9BDQ37868503-F5730F7B-BF74-492E-AA91-7F47FAB0B4A0Q37876312-68E090FA-B538-4585-9EAE-D0EE4BB21ECCQ37876392-D0FE6424-8382-495B-A954-95F913DEA05BQ37877962-D394270C-0154-4DEF-81CC-DF227FC6FA6CQ37878142-0A0BCEA5-414A-4331-990B-E36567811B13Q37878292-91709837-7590-43BE-BE6D-2CEBE71781BEQ37881193-5A69A730-BC48-4BA8-9F40-8C816262D640Q37883200-600FF304-CCFA-4AF8-A5AE-D65BFFC0416CQ37883633-0D1A6C5A-7051-4CFC-9B77-F0A139EBFD1DQ37886846-C9F267F3-7080-4652-9E9F-5C8761DB8378Q37889709-2B240B76-1061-450D-B449-85A0C1219F66
P2860
Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979.
@en
Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979.
@nl
type
label
Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979.
@en
Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979.
@nl
prefLabel
Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979.
@en
Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979.
@nl
P2093
P356
P1476
Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979.
@en
P2093
P304
P356
10.1093/INFDIS/166.3.646
P407
P577
1992-09-01T00:00:00Z